publication . Article . 2020

Use of biologicals in allergic and type 2 inflammatory diseases in the current COVID-19 pandemic

Klimek, Ludger; Pfaar, Dr O.; Worm, Margitta M.; Eiwegger, Thomas; Hagemann, Jan; Ollert, Markus W.; Untersmayr, Eva; Hoffmann-Sommergruber, Karin; Vultaggio, Alessandra; Agache, Ioana O.; ...
  • Published: 01 Jan 2020
  • Publisher: HAL CCSD
  • Country: France
International audience
ACM Computing Classification System: ComputingMilieux_MISCELLANEOUS
free text keywords: Benralizumab, Covid-19, Dupilumab, Mepolizumab, Omalizumab, Reslizumab, SARS-CoV-2, Telemedicine, [SDV]Life Sciences [q-bio]
Related Organizations
Any information missing or wrong?Report an Issue